Panelists discuss how understanding EGFR mutations has transformed the treatment landscape for non–small cell lung cancer ...

In EGFR-mutated advanced NSCLC, first line osimertinib plus platinum-pemetrexed prolonged overall survival versus monotherapy ...

Responses were rapid and durable, and tumour shrinkage was observed in 82 percent of patients[i] New findings from this investigational study build on the strength of the data for amivantamab in ...

BERLIN -- Almost half of patients with advanced ALK -positive non-small cell lung cancer (NSCLC) have lived 7 years or longer ...

Combining osimertinib with LCT significantly improved PFS in metastatic EGFR-mutant NSCLC, reducing disease progression risk by 34%. The trial showed enhanced PFS across different EGFR mutation ...

Tagrisso combined with chemotherapy improved overall survival in EGFR-mutated NSCLC patients, including those with poor ...

Legendary actor and philanthropist William Shatner has joined forces with IdentifySensors Biologics, a pioneer in digital molecular diagnostics, to announce that the company has raised more than $20 ...

Black Diamond Therapeutics focuses on silevertinib, a next-gen EGFR inhibitor for NSCLC, after outlicensing its other lead asset to Servier.

Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the CTNNB1 gene mutation associated with various aggressive cancers such as ...

1 Department of Radiology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China 2 Medical Imaging Research Center, Anhui Medical University, Hefei, China Objective: Despite the ...

Osimertinib (Tagrisso) combined with chemotherapy significantly improved overall survival (OS) compared with osimertinib alone as frontline treatment for patients with EGFR-mutated advanced non–small ...

CURE spoke with Dr. Xiuning Le during the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer. Lung cancer research has recognized the role of EGFR ...